Abstract
Background A unique concern pertaining to the spread of COVID-19 across countries is the asymmetry of risk and the irrational fear of a new pandemic and its possible serious consequences. This study aimed to perform a time series analysis on the association between climate factors and daily cases of COVID-19 in Malaysia up to 15 July 2020. The second objective was to predict daily new cases using a forecasting technique. To address within-country variations, the analysis was extended to the state level with Sarawak state as an example.
Methodology/Principal Findings Datasets on the daily confirmed cases and climate variables in Malaysia and Sarawak state were obtained from publicly accessible official websites. A descriptive analysis was performed to characterize all the important variables over the study period. An autoregressive integrated moving average (ARIMA) model was introduced using daily cases as the dependent variable and climate parameters as the explanatory variables.
For Malaysia, the findings suggest that, ceteris paribus, the number of COVID-19 cases decreased with increasing average temperature (p=0.003) or wind speed (p=0.029). However, none of the climate parameters showed a significant relationship with the number of COVID-19 cases in Sarawak state. Forecasts from the ARIMA models showed that new daily COVID-19 cases had already reached the outbreak level and a decreasing trend in both settings. Holding other parameters constant, a small number of new cases (approximately a single digit) is a probable second wave in Sarawak state,
Conclusions/Significance The findings suggest that climate parameters and forecasts are helpful for reducing the uncertainty in the severity of future COVID-19 transmission. A highlight is that forecasts will be a useful tool for making decisions and taking the appropriate interventions to contain the spread of the virus in the community.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
None
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
An exemption given as we used solely on data that are publically accessible .
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The availability of all data in the manuscript and supporting information.
